Literature DB >> 17257467

Impact of overactive bladder on women in the United States: results of a national survey.

Roger R Dmochowski1, Diane K Newman.   

Abstract

BACKGROUND: Overactive bladder (OAB) may affect health-related quality of life. Few data have been gathered on the impact of OAB or on patient satisfaction with therapy. This 2002 survey examined the effects of OAB on participants; treatment-seeking behaviors, patient satisfaction with oral OAB therapies, and desirable characteristics of new treatments were investigated.
METHODS: An online questionnaire was administered to 1228 women aged 40-65 years with at least a high school education and minimum annual income of 35,000 dollars. Respondents were categorized as having no OAB symptoms (control group; n = 330) or as having OAB symptoms (n = 898). Those with symptoms were subdivided into treatment groups: current users of prescription OAB medications (n = 309), lapsed prescription medication users (n = 265), and those never treated (n = 324). The significance of between-group differences in response was assessed through 95% confidence levels.
RESULTS: Symptoms of OAB significantly affect self-esteem, family relations, sexual relations, lifestyle, professional life, and health perception. More than half of women who discussed OAB with a health care provider (56%) waited longer than 1 year to seek treatment; many attempted to self-manage symptoms. Health care providers rarely screen for OAB, leaving many conditions undiagnosed and patients untreated. Women treated for OAB expressed significant dissatisfaction with current OAB therapies and the desire for more effective, convenient treatments with fewer adverse effects.
CONCLUSIONS: Likely outcomes should be discussed with patients before treatment is initiated so that expectations are realistic and patients' overall satisfaction with treatment is enhanced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257467     DOI: 10.1185/030079907X159533

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  30 in total

1.  The Burden of Overactive Bladder on US Public Health.

Authors:  W Stuart Reynolds; Jay Fowke; Roger Dmochowski
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-01-23

2.  Inpatient bladder retraining: is it beneficial on its own?

Authors:  Amitabha Majumdar; Ismail Hassan; Sepeedeh Saleh; Philip Toozs-Hobson
Journal:  Int Urogynecol J       Date:  2010-01-30       Impact factor: 2.894

Review 3.  Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms.

Authors:  Tamara G Bavendam; Jenna M Norton; Ziya Kirkali; Chris Mullins; John W Kusek; Robert A Star; Griffin P Rodgers
Journal:  J Urol       Date:  2016-06-21       Impact factor: 7.450

4.  Exploratory analysis of the effect of mirabegron on urodynamic sensation parameters and urethral pressure variations.

Authors:  Maxime T M Kummeling; Joost Egberts; Henk W Elzevier; Gommert A van Koeveringe; Hein Putter; Pieter M Groenendijk
Journal:  Int Urogynecol J       Date:  2020-02-03       Impact factor: 2.894

5.  InterStim Therapy: A Contemporary Approach to Overactive Bladder.

Authors:  Neeraj Kohli; Danielle Patterson
Journal:  Rev Obstet Gynecol       Date:  2009

6.  Basal and stress-activated hypothalamic pituitary adrenal axis function in postmenopausal women with overactive bladder.

Authors:  Ariana L Smith; Liisa Hantsoo; Anna P Malykhina; Daniel W File; Rita Valentino; Alan J Wein; Mary D Sammel; C Neill Epperson
Journal:  Int Urogynecol J       Date:  2016-03-04       Impact factor: 2.894

Review 7.  Neuromodulation for overactive bladder.

Authors:  Jamie Bartley; Jason Gilleran; Kenneth Peters
Journal:  Nat Rev Urol       Date:  2013-07-02       Impact factor: 14.432

8.  European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.

Authors:  Vik Khullar; Daniela Marschall-Kehrel; Montserrat Espuna-Pons; Con J Kelleher; Shannon E Tully; Elisabeth C Piault; Linda Brubaker; Aino Fianu-Jonasson; David Weinstein; Agneta Bergqvist; Marion Kvasz
Journal:  Int Urogynecol J       Date:  2013-04-09       Impact factor: 2.894

9.  Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial.

Authors:  Mel Lauti; Peter Herbison; Jean Hay-Smith; Gaye Ellis; Don Wilson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-07-25

Review 10.  Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.

Authors:  J F Wyman; K L Burgio; D K Newman
Journal:  Int J Clin Pract       Date:  2009-07-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.